There is a major clinical need for better biomarkers to identify Diabetic Kidney Disease (DKD) patients at risk of progression. iBEAt is a prospective multi-centre cohort study in 500 patients aiming to determine if MRI biomarkers can provide prediction of progression. We have developed a dedicated MRI biomarker panel for iBEAt interrogating body composition, renal morphology and tissue structure, hemodynamics and filtration. Here we present the details as well as example data and preliminary results on the ISMRM/NIST phantom, and on healthy volunteers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords